title: An update on facial transplantation cases performed between 2005 and 2010.
abstract: BACKGROUND
  Since 2005, 13 facial allotransplantation cases have been performed worldwide. The major indications for these facial allotransplantations were neurofibromatosis and trauma injuries, including animal bites, burns, falls, and shotgun blasts.
  
  
  METHODS
  An analysis of 13 facial transplantation cases was performed by reviewing the anatomical details, microsurgical techniques, and functional outcomes according to the follow-up information based on the literature, meeting presentations, and media reports.
  
  
  RESULTS
  The male-to-female ratio was 11:2. Two male patients died at 2 months and 2 years, respectively, after transplantation because of transplant- and infection-related problems. Eleven face transplant recipients are alive. The composite tissue allotransplants included cutaneous, myocutaneous, and osteomyocutaneous components. Most of these facial allotransplants were partial, one was nearly total, and two were announced as total face transplantations.
  
  
  CONCLUSIONS
  This report provides a useful overview of the technical aspects of face transplantation; however, the reports on long-term functional and aesthetic outcomes will help to define the future of face transplantation.
authors.affiliation: Cleveland, Ohio From the Dermatology and Plastic Surgery Institute, Cleveland Clinic.
authors.forename: Maria
authors.initials: M
authors.lastname: Siemionow
authors.forename: Can
authors.initials: C
authors.lastname: Ozturk
mesh_terms: D000328:Adult; D005151:Facial Injuries / Q000601:surgery; D005153:Facial Neoplasms / Q000601:surgery; D054445:Facial Transplantation / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008866:Microsurgery / Q000379:methods*; D008875:Middle Aged; D017253:Neurofibromatoses / Q000601:surgery; D011183:Postoperative Complications / Q000209:etiology* / Q000401:mortality; D013524:Surgical Flaps; D016019:Survival Analysis; D014019:Tissue Donors